RHJA
GEN

Rice Hall James & Associates’s Genesis Healthcare, Inc. GEN Stock Holding History

Rice Hall James & Associates’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-231,088
Closed -$1.42M – 317
2015
Q3 		$1.42M Buy
+231,088
New +$1.57M 0.09% 213

Other funds holding GEN

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return

Rice Hall James & Associates's GEN Position: Q4 2015 in Review

Rice Hall James & Associates sold out of Genesis Healthcare, Inc. (GEN) in Q4 2015, closing a stake of 231,088 shares — an estimated $1.42M sold.

Rice Hall James & Associates first reported a position in GEN in Q3 2015 and held it in 1 quarter. The position peaked at $1.42M in Q3 2015. 82 funds tracked by Wall St. Rank hold GEN as of Q4 2015.

  • Rice Hall James & Associates reported no remaining Genesis Healthcare, Inc. position as of Q4 2015 after selling out during the quarter.
  • Rice Hall James & Associates sold 231,088 Genesis Healthcare, Inc. shares in Q4 2015, an estimated $1.42M.
  • Rice Hall James & Associates first reported a position in Genesis Healthcare, Inc. in Q3 2015 and held it in 1 quarter.
  • Rice Hall James & Associates's Genesis Healthcare, Inc. position peaked at $1.42M in Q3 2015.
  • 82 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2015.

Based on Rice Hall James & Associates's 13F filing for Q4 2015, filed 28 Jan 2016.